Clinical Trial

ACT for Mental Health in Neurological Disorders

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to examine the efficacy of this manual for mental health in people with mixed neurological disorders, including post-COVID. These conditions are often associated with cognitive impairment, which may hamper the effects of psychoterapy. Executive functioning and especially the ability to abstract thinking may be useful for individuals using Acceptance and Commitment Therapy. Therefore, the main questions research questions are: * Is this intervention effective in improving mental health? * Do executive functions predict the extent of social participation and mental health at the end of therapy? Participants will take part in 8 weekly group therapy sessions of 100 minutes each.
Trial Details
NCT Number NCT06897553
Lead Sponsor Bielefeld University
Conditions Neurological Disorders, Mental Health, Executive Function (Cognition), Depression/Anxiety, Stress, Brain Injury, Post-COVID
Enrollment 44 participants
Start Date 2024-12-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-27